Cancer Treatment Centers of America Expands MedAssets Relationship to Enhance Onsite Advanced Treatment Accommodations

  Cancer Treatment Centers of America Expands MedAssets Relationship to
  Enhance Onsite Advanced Treatment Accommodations

  MedAssets Capital and Construction Solutions selected to improve savings,
  transparency and collaboration on remodeling and expansion efforts across
            national network of state-of-the-art cancer hospitals

Business Wire

ATLANTA -- March 13, 2013

MedAssets (NASDAQ: MDAS) today announced that Cancer Treatment Centers of
America (CTCA) has engaged the company to help drive cost savings for
construction projects across its national network of hospitals. The new
agreement to use MedAssets Capital and Construction Solutions builds upon
CTCA’s current relationship with MedAssets for Strategic Sourcing services,
Charge Integrity and Reimbursement Integrity solutions to drive better
operational and financial performance.

According to Kimberly Alvord, corporate director of Supply Chain at CTCA,
expansion and remodeling efforts at each treatment center is in response to
growing demand for new, additional services that address all aspects of
treating complex and advanced stages of cancer. Each of the state-of-the-art
cancer hospitals houses the latest treatment technologies and experienced
clinical staff, while at the same time is designed to be warm and comforting.

“MedAssets offers a technology-enabled service that delivers a single solution
for comparing and purchasing construction items, which will be invaluable in
saving our team time, cost and energy as we enhance our facilities to better
meet the needs of our patients and their families,” said Alvord. “Moreover, by
centralizing buying decisions and utilizing expert analysis and market
intelligence data, we expect to achieve operational efficiencies and
significant financial improvement in our projects.”

Managing Projects across Multiple Facilities for Better Aggregation

With MedAssets, CTCA gains access to a cloud-based solution for enhanced
visibility and financial control of construction and renovation projects
across all stages—from planning and predictive analysis to management. The
network plans to use the solution suite’s models to budget and plan for
overall increased visibility and enhanced collaboration among its facilities.

“The increase in demand for healthcare facility construction in a time of
unprecedented economic challenge makes it imperative to identify and avoid the
common, yet costly mistakes organizations make before, during and after a
construction project,” said Cheryl Stoddard, vice president, Construction
Solutions, MedAssets. “MedAssets is pleased that CTCA has selected our
solution as it works to achieve on-time and under-budget construction and
renovation projects.”

About Cancer Treatment Centers of America

Cancer Treatment Centers of America, Inc. (CTCA) is a national network of
hospitals focusing on complex and advanced stage cancer. CTCA offers a
comprehensive, fully integrated approach to cancer treatment and serves
patients from all 50 states at facilities located in Atlanta, Chicago,
Philadelphia, Phoenix and Tulsa. Known for delivering the Mother Standard® of
care and Patient Empowerment Medicine®, CTCA provides patients with
information about cancer and their treatment options so they can control their
treatment decisions. For more information about CTCA, go to

About MedAssets

MedAssets (NASDAQ: MDAS) partners with healthcare providers to improve their
financial strength by implementing revenue cycle, spend and clinical resource
management solutions that help capture revenue, control cost, improve margins
and cash flow, increase regulatory compliance, and optimize operational
efficiency. MedAssets serves more than 4,200 hospitals and 122,000 non-acute
healthcare providers. The company currently manages $50 billion in supply
spend and touches over $365 billion in gross patient revenue annually through
its revenue cycle solutions. For more information, go to



Media Contact:
Robin Wrinn, 678-624-7420
Investor Contact:
Robert Borchert, 678-248-8194
Press spacebar to pause and continue. Press esc to stop.